Dr. Hassan Al Amri

Dr. Hassan Al Amri

Dr.hassan alamri

Profile:

  Dr. Hassan Al-Amri is Assistant Professor of Clinical Chemistry at King Saud bin Abdulaziz University for Health Sciences.
 Dr. Al-Amri completed his Master training in Clinical Chemistry at Rochester Institute of Technology and his PhD training in Clinical-Bioanalytical Chemistry (with specialization in Clinical Chemistry) at Cleveland State University at Cleveland Clinic Campus, which is the only accredited PhD program in the United States (accredited by the Commission on Accreditation in Clinical Chemistry).
 Dr. Al-Aamri's research lies in the field of metabolomics. His research involves developing liquid chromatography-mass spectrometry methods for the measurement and characterization of metabolites in biological fluids, for the purpose of understanding disease processes and discovering new biomarkers of disease, in particular cardiovascular diseases and inborn error of metabolism.

  • Education & Membership

  • Publications

  • Contact Information


Education:

2018 Cleveland State University at Cleveland Clinic Campus, Cleveland, Ohio, USA. PhD’s Degree in Clinical-bioanalytical Chemistry with specialization in Clinical Chemistry.
2011 Rochester Institute of Technology, Rochester, New York, USA. Master’s Degree in Clinical Chemistry.
2008 King Khalid University, Abha, Saudi Arabia. Bachelor of Medical Laboratory Science.

Membership:

  • American Association for Clinical Chemistry (AACC)
  • American Society for Mass Spectrometry (ASMS)
  • Metabolomics Society
  • The Human Proteome Organization (HUPO)

  • Li, X. S.; Obeid, S.; Klingenberg, R.; Gencer, B.; Mach, F.; Raeber, L.; Windecker, S.; Rodondi, N.; Nanchen, D.; Mueller, O.; Miranda, M. X.; Matter, C. M.; Wu, Y.; Li, L.; Wang, Z.; Alamri, H. S.; Gogonea, V.; Chung, Y.-M.; Tang, W. H. W.; Hazen, S. L.; Luescher, T. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndroms: A prognostic marker for incident cardiovascular events beyond traditional risk factors, European heart journal 38.11 (2017). (Impact factor 2016: 20)
  • Alamri, H.; Nemet, I.; Nimer, N.; Cajka, T.; Fiehn, O.; Gogonea, V.; Hazen, S. L. “Identification of specific sugar alcohol as predictors of incident CVD risks”, 36th Annual Lerner Research Institute Research Day, Cleveland Clinic, Cleveland, Ohio, September 25th, 2016 (poster presentation).
  • Alamri, H.; Choucair, I.; Nimer, N.; Nemet, I.; Cajka, T.; Fiehn, O.; Hazen, S. L.; Gogonea, V. “Novel Biomarker for Cardiovascular Disease”, College of Science and Health Professions Research Day, Cleveland State University, Cleveland, Ohio, April 8th, 2016 (poster presentation).
  • Alamri, H.; Levison, B.; Cajka, T.; Fiehn, O.; Hazen, S. L.; Gogonea, V. “Analysis of selected carboxylic acids and amino acids in clinical samples of patients at risk for cardiovascular disease”, USHUPO 12th Annual Conference, US Human Proteome Organization, Boston, Massachusetts, March 13th, 2016 (poster presentation).
  • Alamri, H.; Choucair, I.; Nimer, N.; Nemet, I.; Cajka, T.; Fiehn, O.; Hazen, S. L.; Gogonea, V. “Identification of Novel Biomarker for Cardiovascular Disease Risk by Mass Spectrometry-based Metabolomics”, ACS Meeting in-Miniature, Case Western Reserve University, Cleveland, Ohio, March 11th, 2016 (oral presentation).

E-mail: Amrihksau-hs
Phone:
 +966 11 4299999
Ext: 
95595